C5’s 26th Forum on
26th-27th March 2014
Hotel Vier Jahreszeiten Kempinski, Munich, Germany
Biotech drugs account for around nearly 15% of the current pharmaceutical market and is recognised as a major growth area for the pharma industry. Pharma companies spend billions on biotech R&D but resulting inventions are only as valuable as the patents they can obtain, to allow them to exploit such inventions commercially and, as far as possible, to the exclusion of competitors.
Our 2014 Biotech Patenting Forum will focus on the practical solutions to the current challenges facing pharma and biotech companies, patent attorneys, legal practitioners and regulatory officers. You will hear the specific strategies used by industry experts in dealing with biotech patenting challenges which will impact your company in 2014 and beyond.
You will have a chance to listen to a discussion regarding the new Unified Patent Court by two European judges who are very closely associated with the new institution and our Industry Panel will offer valuable insights into the different considerations and dilemmas faced by in-house counsel regarding this new European system.
Join us and hear the latest strategies for maximising your product revenue by ensuring your international patent portfolio is protected.
It is imperative that you get up to speed on the relevant key updates and know how to overcome the most challenging issues that remain in this field.
For speaking opportunities please contact:
Christos Apostolou, Conference Producer
Tel: +44(0)20 7878 6957
For sponsorship opportunities please contact:
Tel: +44(0)20 7878 6955
For media partnership opportunities please contact:
Tel: +44(0)20 7878 6956